291 related articles for article (PubMed ID: 30021268)
1. Occurrence and distribution of carbamazepine, nicotine, estrogenic compounds, and their transformation products in wastewater from various treatment plants and the aquatic environment.
Ekpeghere KI; Sim WJ; Lee HJ; Oh JE
Sci Total Environ; 2018 Nov; 640-641():1015-1023. PubMed ID: 30021268
[TBL] [Abstract][Full Text] [Related]
2. Occurrence and removal of frequently prescribed pharmaceuticals and corresponding metabolites in wastewater of a sewage treatment plant.
Gurke R; Rößler M; Marx C; Diamond S; Schubert S; Oertel R; Fauler J
Sci Total Environ; 2015 Nov; 532():762-70. PubMed ID: 26124013
[TBL] [Abstract][Full Text] [Related]
3. Estrogenic compounds in Tunisian urban sewage treatment plant: occurrence, removal and ecotoxicological impact of sewage discharge and sludge disposal.
Belhaj D; Athmouni K; Jerbi B; Kallel M; Ayadi H; Zhou JL
Ecotoxicology; 2016 Dec; 25(10):1849-1857. PubMed ID: 27660067
[TBL] [Abstract][Full Text] [Related]
4. Presence and fate of carbamazepine, oxcarbazepine, and seven of their metabolites at wastewater treatment plants.
Leclercq M; Mathieu O; Gomez E; Casellas C; Fenet H; Hillaire-Buys D
Arch Environ Contam Toxicol; 2009 Apr; 56(3):408-15. PubMed ID: 18779941
[TBL] [Abstract][Full Text] [Related]
5. Investigation of PPCPs in wastewater treatment plants in Greece: occurrence, removal and environmental risk assessment.
Kosma CI; Lambropoulou DA; Albanis TA
Sci Total Environ; 2014 Jan; 466-467():421-38. PubMed ID: 23933429
[TBL] [Abstract][Full Text] [Related]
6. Occurrence and removal of selected pharmaceuticals and personal care products in three wastewater-treatment plants.
Kwon JW; Rodriguez JM
Arch Environ Contam Toxicol; 2014 May; 66(4):538-48. PubMed ID: 24357097
[TBL] [Abstract][Full Text] [Related]
7. Occurrence of selected pharmaceuticals in the principal sewage treatment plants in Rome (Italy) and in the receiving surface waters.
Patrolecco L; Capri S; Ademollo N
Environ Sci Pollut Res Int; 2015 Apr; 22(8):5864-76. PubMed ID: 25352396
[TBL] [Abstract][Full Text] [Related]
8. Seasonal variation of endocrine disrupting compounds, pharmaceuticals and personal care products in wastewater treatment plants.
Yu Y; Wu L; Chang AC
Sci Total Environ; 2013 Jan; 442():310-6. PubMed ID: 23178835
[TBL] [Abstract][Full Text] [Related]
9. Environmental risk assessment of selected pharmaceuticals in hospital wastewater in nothern Vietnam.
Hoang ATP; Do MC; Kim KW
Chemosphere; 2024 May; 356():141973. PubMed ID: 38608777
[TBL] [Abstract][Full Text] [Related]
10. Factors Affecting Distribution of Estrogenicity in the Influents, Effluents, and Biosolids of Canadian Wastewater Treatment Plants.
Shieh BH; Louie A; Law FC
Arch Environ Contam Toxicol; 2016 May; 70(4):682-91. PubMed ID: 26433808
[TBL] [Abstract][Full Text] [Related]
11. Detection of pharmaceuticals and phytochemicals together with their metabolites in hospital effluents in Japan, and their contribution to sewage treatment plant influents.
Azuma T; Arima N; Tsukada A; Hirami S; Matsuoka R; Moriwake R; Ishiuchi H; Inoyama T; Teranishi Y; Yamaoka M; Mino Y; Hayashi T; Fujita Y; Masada M
Sci Total Environ; 2016 Apr; 548-549():189-197. PubMed ID: 26802347
[TBL] [Abstract][Full Text] [Related]
12. Which type of pollutants need to be controlled with priority in wastewater treatment plants: Traditional or emerging pollutants?
Zhou Y; Meng J; Zhang M; Chen S; He B; Zhao H; Li Q; Zhang S; Wang T
Environ Int; 2019 Oct; 131():104982. PubMed ID: 31299603
[TBL] [Abstract][Full Text] [Related]
13. Bioassay of estrogenic activity of effluent and influent in a farm wastewater treatment plant using an in vitro recombinant assay with yeast cells.
Li XM; Luo FN; Liu GX; Zhu PT
Biomed Environ Sci; 2008 Oct; 21(5):381-8. PubMed ID: 19133611
[TBL] [Abstract][Full Text] [Related]
14. Investigation and risk evaluation of the occurrence of carbamazepine, oxcarbazepine, their human metabolites and transformation products in the urban water cycle.
Brezina E; Prasse C; Meyer J; Mückter H; Ternes TA
Environ Pollut; 2017 Jun; 225():261-269. PubMed ID: 28408188
[TBL] [Abstract][Full Text] [Related]
15. Fate of selected pharmaceuticals in hospital and municipal wastewater effluent: occurrence, removal, and environmental risk assessment.
Ulvi A; Aydın S; Aydın ME
Environ Sci Pollut Res Int; 2022 Oct; 29(50):75609-75625. PubMed ID: 35655023
[TBL] [Abstract][Full Text] [Related]
16. Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada.
Lishman L; Smyth SA; Sarafin K; Kleywegt S; Toito J; Peart T; Lee B; Servos M; Beland M; Seto P
Sci Total Environ; 2006 Aug; 367(2-3):544-58. PubMed ID: 16697441
[TBL] [Abstract][Full Text] [Related]
17. Occurrence and distribution of pharmaceuticals in wastewater from households, livestock farms, hospitals and pharmaceutical manufactures.
Sim WJ; Lee JW; Lee ES; Shin SK; Hwang SR; Oh JE
Chemosphere; 2011 Jan; 82(2):179-86. PubMed ID: 21040946
[TBL] [Abstract][Full Text] [Related]
18. Occurrence, fate and environmental risk assessment of endocrine disrupting compounds at the wastewater treatment works in Pietermaritzburg (South Africa).
Manickum T; John W
Sci Total Environ; 2014 Jan; 468-469():584-97. PubMed ID: 24056449
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of pharmaceuticals and personal care products with emphasis on anthelmintics in human sanitary waste, sewage, hospital wastewater, livestock wastewater and receiving water.
Sim WJ; Kim HY; Choi SD; Kwon JH; Oh JE
J Hazard Mater; 2013 Mar; 248-249():219-27. PubMed ID: 23357510
[TBL] [Abstract][Full Text] [Related]
20. Occurrence and removal of pharmaceutical and hormone contaminants in rural wastewater treatment lagoons.
Li X; Zheng W; Kelly WR
Sci Total Environ; 2013 Feb; 445-446():22-8. PubMed ID: 23314119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
